BioPractica OCUVIZION CAPSULE
BioPractica OCUVIZION CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| TAGETES ERECTA (MARIGOLD) EXTRACT | TAGETES ERECTA (MARIGOLD) EXTRACT[50 mg,600 mg] | Not identified |
| Retinyl Acetate (Vitamin A) | Retinyl Acetate (Vitamin A)[4 mg,600 mg] | Vitamine A |
| CALCIUM ASCORBATE DIHYDRATE | CALCIUM ASCORBATE DIHYDRATE[126.11 mg,600 mg] | Vitamine C |
| DL-ALPHA TOCOPHERYL ACETATE | DL-ALPHA TOCOPHERYL ACETATE[50 mg,600 mg] | Vitamine E |
| ZINC BISGLYCINATE | ZINC BISGLYCINATE[30 mg,600 mg] | Zinc |
| L-SELENOMETHIONINE | L-SELENOMETHIONINE[6.4 mg,600 mg] | Sélénium |
| VACCINIUM MYRTILLUS FRUIT EXTRACT (BILBERRY) | VACCINIUM MYRTILLUS FRUIT EXTRACT (BILBERRY)[100 mg,600 mg] | Not identified |
| VITIS VINIFERA (GRAPE SEED EXTRACT) | VITIS VINIFERA (GRAPE SEED EXTRACT)[150 mg,600 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL23086045NC
- Type
- Health supplement
- Published status
- PRODUCT APPROVED
- Licence holder
- STELLAR BIO SDN BHD
- Manufacturer
- Esprit Care Sdn. Bhd.
- Registration period starting
- 2023-08-23
- Published validity end
- 2028-08-23
Original register data
View published fields and their variants
- Active ingredients
- TAGETES ERECTA (MARIGOLD) EXTRACT[50 mg,600 mg],Retinyl Acetate (Vitamin A)[4 mg,600 mg],CALCIUM ASCORBATE DIHYDRATE[126.11 mg,600 mg],DL-ALPHA TOCOPHERYL ACETATE[50 mg,600 mg],ZINC BISGLYCINATE[30 mg,600 mg],L-SELENOMETHIONINE[6.4 mg,600 mg],VACCINIUM MYRTILLUS FRUIT EXTRACT (BILBERRY)[100 mg,600 mg],VITIS VINIFERA (GRAPE SEED EXTRACT)[150 mg,600 mg]
- Valid until
- 2028-08-23
- Registration date
- 2023-08-23
- Published description
- HEALTH SUPPLEMENT
- Licence holder
- STELLAR BIO SDN BHD
- Producer
- Esprit Care Sdn. Bhd.
- Published name
- BioPractica OCUVIZION CAPSULE
- Published reference
- 2023052411437N
- Registration number
- MAL23086045NC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL23086045NC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BioPractica OCUVIZION CAPSULE”, https://compoatlas.com/en/supplements/malaysia/MAL23086045NC-biopractica-ocuvizion-capsule, updated 27 October 2026.